The weekly litigation news digest is live. Subscribe now

IP Verse

Adjuvanting Meningococcal Factor H Binding Protein

Patent No. EP2411048 (titled "Adjuvanting Meningococcal Factor H Binding Protein") was filed by Glaxosmithkline on Mar 24, 2010. The application was issued on May 6, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SANOFI PASTEURFeb 5, 2021ZWICKER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2411048

GLAXOSMITHKLINE
Application Number
EP10713516A
Filing Date
Mar 24, 2010
Status
Granted And Under Opposition
Apr 3, 2020
Publication Date
May 6, 2020
External Links
Slate, EP2411048B1, Google Patents